Culturally adapted brief counseling to reduce alcohol problems in Hispanic adults
Stage II Efficacy Trial of an Adapted Brief Intervention to enhance healthcare and health outcomes among Hispanics
A short, culturally tailored counseling session designed to help Hispanic adults lower alcohol-related problems and connect with health care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas El Paso NIH-funded |
| Lab location | 1 site (El Paso, United States) |
| Project ID | NIH-11128330 on NIH RePORTER |
What this research studies
You would be offered a brief, flexible counseling session adapted to Hispanic cultural values that focuses on reducing alcohol harm and increasing use of care. The intervention supports your autonomy, relatedness, and confidence to make changes in drinking using a harm-reduction approach. This Stage II trial, built on community input and a prior pilot, compares the adapted counseling to standard brief interventions and follows participants over time to track drinking, alcohol problems, and treatment use. Participation typically involves one or a few brief sessions and follow-up assessments in person or by phone.
Who could benefit from this research
Good fit: Hispanic adults who drink at risky levels or have alcohol-related problems and are willing to take part in brief counseling and follow-up assessments.
Not a fit: People who do not drink or those with severe alcohol dependence who need intensive inpatient care may not benefit from this brief intervention.
Why it matters
Potential benefit: If successful, this could help Hispanic patients reduce harmful drinking, experience fewer alcohol-related problems, and better access health services.
How similar studies have performed: Earlier large trials and a small pilot showed promise for brief interventions among Hispanics and this adapted approach has shown feasibility and early positive signals, though more rigorous testing is needed.
Where this research is happening
El Paso, United States
- University of Texas El Paso — El Paso, United States (Active)
Researchers
- Principal investigator: Field, Craig a — University of Texas El Paso
- Study coordinator: Field, Craig a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.